Affiliation:
1. Vice President´s Research Group: Molecular Allergology Paul‐Ehrlich‐Institut Langen (Hesse) Germany
2. Environmental Medicine Faculty of Medicine University of Augsburg Augsburg Germany
3. Department of Pediatric Pneumology Allergology and Neonatology Hannover Medical School Hannover Germany
4. Department of Dermatology University Medical Center of the Johannes Gutenberg‐University Mainz Mainz Germany
Abstract
AbstractAntigen‐presenting cells (APCs) are critical cells bridging innate and adaptive immune responses by taking up, processing, and presenting antigens to naïve T cells. At steady state, APCs thus control both tissue homeostasis and the induction of tolerance. In allergies however, APCs drive a Th2‐biased immune response that is directed against otherwise harmless antigens from the environment. The main types of APCs involved in the induction of allergy are dendritic cells, monocytes, and macrophages. However, these cell types can be further divided into local, tissue‐specific populations that differ in their phenotype, migratory capacity, T‐cell activating potential, and production of effector molecules. Understanding if distinct populations of APCs contribute to either tissue‐specific immune tolerance, allergen sensitization, or allergic inflammation will allow us to better understand disease pathology and develop targeted treatment options for different stages of allergic disease. Therefore, this review describes the main characteristics, phenotypes, and effector molecules of the APCs involved in the induction of allergen‐specific Th2 responses in affected barrier sites, such as the skin, nose, lung, and gastrointestinal tract. Furthermore, we highlight open questions that remain to be addressed to fully understand the contribution of different APCs to allergic disease.
Subject
Immunology,Immunology and Allergy